Drug treatment of lipid disorders

N Engl J Med. 1999 Aug 12;341(7):498-511. doi: 10.1056/NEJM199908123410707.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Anion Exchange Resins / adverse effects
  • Anion Exchange Resins / therapeutic use
  • Cardiovascular Diseases / etiology
  • Clofibrate / adverse effects
  • Clofibrate / therapeutic use
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hyperlipidemias / complications
  • Hyperlipidemias / diet therapy
  • Hyperlipidemias / drug therapy*
  • Hypolipidemic Agents / adverse effects
  • Hypolipidemic Agents / therapeutic use*
  • Male
  • Niacin / adverse effects
  • Niacin / therapeutic use
  • Risk Factors

Substances

  • Anion Exchange Resins
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • Niacin
  • Clofibrate